Posts

Continuous vs. Bolus Norepinephrine for Post-Induction Hypotension

-
Continuous vs. Bolus Norepinephrine for Post-Induction Hypotension Continuous vs. Bolus Norepinephrine for Post-Induction Hypotension: A Landmark Trial Key Takeaway: Continuous infusion of norepinephrine offers no significant advantage over manual bolus administration in reducing post-induction hypotension in low-to-moderate risk noncardiac surgery patients, according to a randomized trial in the British Journal of Anaesthesia . Study Design Participants: 276 patients (261 analyzed) undergoing elective noncardiac surgery Interventions: Randomized to continuous infusion (target: 0.05 µg/kg/min) or manual boluses (10 µg) Monitoring: Intermittent oscillometric BP + blinded continuous finger-cuff monitoring Primary Endpoint: Area under MAP Key Findings Metric Continuous Infusion Bolus Administration Area under MA...
Read more

Danavorexton (TAK-925): A Promising Breakthrough in Combating Opioid-Induced Respiratory Depression

-
Danavorexton (TAK-925): A Promising Breakthrough in Combating Opioid-Induced Respiratory Depression Danavorexton (TAK-925): A Promising Breakthrough in Combating Opioid-Induced Respiratory Depression Opioids remain a cornerstone of pain management in clinical settings, yet their use is shadowed by life-threatening side effects, including respiratory depression and excessive sedation. A recent podcast episode from Anesthesiology ’s featured author series highlights a groundbreaking solution: danavorexton (TAK-925) , an orexin receptor 2 agonist that could revolutionize how we manage opioid-related complications. What Is Danavorexton (TAK-925)? Danavorexton is a selective agonist of the orexin-2 receptor (OX2R), a key player in regulating wakefulness and respiration. Orexins (also known as hypocretins) are neuropeptides produced in the hypothalamus that activate OX1R and OX2R receptors, influencing arousal, appetite, and...
Read more

Postreperfusion Syndrome in Liver Transplantation

-
Image
Postreperfusion Syndrome in Liver Transplantation Postreperfusion Syndrome in Liver Transplantation Source: Watch: OpenAnesthesia - "Postreperfusion Syndrome" Date Published: 13/01/2025 Key Themes Definition and Significance Postreperfusion Syndrome (PRS) is a serious complication of liver transplantation, impacting both recipient and graft survival. It's characterised by a significant drop in mean arterial pressure (MAP) within 5 minutes of graft reperfusion. "PRS was originally described as cardiovascular collapse following liver graft reperfusion and defined as a decrease in mean arterial pressure (MAP) of more than 30% below the anhepatic phase baseline within five minutes of reperfusion of the graft, lasting at least one minute." Classification PRS is classified as mild or severe based on the extent and duration of MAP reduction and the ...
Location: United States
Read more

Vein of Galen Malformation Explained: Symptoms, Diagnosis, and Treatment

-
Image
  Briefing Doc: Vein of Galen Malformation (VOGM) Source: OpenAnesthesia. “Vein of Galen Malformation”. Last updated 01/03/2025. Accessed 14/03/2025. Main Themes: Pathophysiology and Clinical Presentation of VOGM: VOGM is a rare congenital arteriovenous fistula posing significant health risks due to its impact on intracranial circulation and the cardiopulmonary system. Diagnosis and Treatment: Early diagnosis is crucial, typically through prenatal ultrasound. Endovascular embolization is the primary treatment, requiring careful anesthetic management. Anesthetic Considerations for VOGM Embolization: Anesthesia for VOGM embolization requires specialized expertise due to the complex physiology, potential cardiac and pulmonary complications, and risk of complications during the procedure. Listen Podcast Key Ideas/Facts: 1. Definition and Impact: "The VOGM is a rare congenital arteriovenous fistula that results in low-resistance intracranial circulation and downstream cardiopulmona...
Location: United States
Read more

Podcast and Review of the Fundamentals, Applications, and Limitations of Cerebral Oximetry

-
Image
Cerebral Oximetry - An Introduction Review of the Fundamentals, Applications, and Limitations of Cerebral Oximetry 1. Executive Summary: This document provides an overview of cerebral oximetry, a non-invasive technique used to monitor brain oxygenation using near-infrared spectroscopy (NIRS). The briefing covers its principles, clinical applications, limitations, and future directions. While cerebral oximetry shows promise for real-time monitoring of cerebral perfusion, particularly in high-risk surgical scenarios, it is essential to understand its limitations and interpret its data with caution. 👉 Ways to Show Your Love & Support for the Channel and blog ❤️Donate & Support My Work: https://bit.ly/4h1uv3G 🩷Support by ko-fi : https://bit.ly/3BYWlyy 💚buy me a cup of coffee ☕: https://bit.ly/3PoqVVe 2. Introduction: The document highlights that "in patients under deep sedation or general anaesthesia, monitoring brain perfusion is crucial for the early detection of cere...
Location: United States
Read more

Evoked Potentials EPs | Podcast | Dr MEK | Anesthesia Lecture

-
Image
👉 Ways to Show Your Love & Support for the Channel and blog ❤️Donate & Support My Work: https://bit.ly/4h1uv3G 🩷Support by ko-fi : https://bit.ly/3BYWlyy 💚buy me a cup of coffee ☕: https://bit.ly/3PoqVVe
Read more

Extended-Release Liposomal Bupivacaine in Peripheral Nerve Blocks: Efficacy, Cost Implications, and Clinical Applications

-
 The article titled " Liposomal Bupivacaine in Peripheral Nerve Blocks " explores the efficacy and utility of liposomal bupivacaine , an extended-release local anesthetic, in managing postoperative pain through peripheral nerve blocks. It discusses both the potential benefits and limitations of using liposomal bupivacaine in clinical practice, particularly for its prolonged analgesic effects after surgeries. Key Points: Mechanism of Action : Liposomal bupivacaine is designed to release the anesthetic bupivacaine over an extended period, typically up to 72 hours after administration. The drug is encapsulated in liposomes, which slowly release the active compound over time. This gradual release allows for a longer duration of pain relief compared to standard formulations of bupivacaine, which typically last for a few hours. Clinical Benefits : The primary advantage of using liposomal bupivacaine in peripheral nerve blocks is the reduction in postoperative pain and potentiall...
Read more